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The cardiac hyperpolarization-activated “funny” current (If), which contributes to sinoatrial
node (SAN) pacemaking, has a more negative half-maximal activation voltage and
smaller fully-activated macroscopic conductance in human than in rabbit SAN cells.
The consequences of these differences for the relative roles of If in the two species,
and for their responses to the specific bradycardic agent ivabradine at clinical doses
have not been systematically explored. This study aims to address these issues, through
incorporating rabbit and human If formulations developed by Fabbri et al. into the Severi
et al. model of rabbit SAN cells. A theory was developed to correlate the effect of If
reduction with the total inward depolarising current (Itotal) during diastolic depolarization.
Replacing the rabbit If formulation with the human one increased the pacemaking cycle
length (CL) from 355 to 1,139ms. With up to 20% If reduction (a level close to the
inhibition of If by ivabradine at clinical concentrations), a modest increase (∼5%) in the
pacemaking CL was observed with the rabbit If formulation; however, the effect was
doubled (∼12.4%) for the human If formulation, even though the latter has smaller
If density. When the action of acetylcholine (ACh, 0.1 nM) was considered, a 20% If
reduction markedly increased the pacemaking CL by 37.5% (∼27.3% reduction in the
pacing rate), which is similar to the ivabradine effect at clinical concentrations. Theoretical
analysis showed that the resultant increase of the pacemaking CL is inversely proportional
to the magnitude of Itotal during diastolic depolarization phase: a smaller If in the model
resulted in a smaller Itotal amplitude, resulting in a slower pacemaking rate; and the same
reduction in If resulted in a more significant change of CL in the cell model with a smaller
Itotal. This explained the mechanism by which a low dose of ivabradine slows pacemaking
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rate more in humans than in the rabbit. Similar results were seen in the Fabbri et al. model
of human SAN cells, suggesting our observations are model-independent. Collectively,
the results of study explain why low dose ivabradine at clinically relevant concentrations
acts as an effective bradycardic agent in modulating human SAN pacemaking.
Keywords: human and rabbit sinoatrial node, funny current, bradycardic agent (ivabradine), electrophysiological
simulation, theoretical analysis
INTRODUCTION
The pacemaker activity of sinoatrial node (SAN) cells in the
mammalian heart arises from the integrated action of multiple
sarcolemmal ionic channel currents and the interaction between
the intracellular calcium handling and sarcolemmal electrogenic
processes (Irisawa et al., 1993; Mangoni and Nargeot, 2008;
Lakatta et al., 2010). The hyperpolarization-activated “funny”
current, If, present in the SAN and other regions of the cardiac
conduction system (Boyett, 2009; Difrancesco, 2010), is produced
by the hyperpolarization-activated cyclic nucleotide gated (HCN)
channel isoforms (of which there are four: HCN1-4), each of
which is comprised of six transmembrane domains with four
subunits combining to produce functional tetrameric channels,
as occurs for voltage-gated potassium channels (Bois et al., 2007;
Difrancesco, 2010). Previous studies of the rabbit SAN have
shown that although HCN isoforms 1, 2, and 4 are all expressed
in the heart, HCN4 is the most abundant in the SAN and the If
density within SAN sub-regions correlates strongly with HCN4
expression levels (Thollon et al., 2007; Brioschi et al., 2009). The
unique features of HCN channels lie in the fact that they are
activated not on depolarization but on hyperpolarization of cell
membrane potential (to voltages negative to∼−40 to∼−50mV)
(Hagiwara and Irisawa, 1989; Accili et al., 1997; Baruscotti et al.,
2005) and are permeable to both Na+ and K+ ions, with an
approximate reversal potential of −30mV (Van Ginneken and
Giles, 1991; Verkerk et al., 2009a). Upon hyperpolarization,
HCN channels generate an inward current over the pacemaking
potential range which, together with the current generated by
other electrogenic processes of the intracellular calcium handling
(i.e., the Ca2+ clock), contributes to the genesis of intrinsic
pacemaker activity of the SAN (Lakatta and Difrancesco, 2009).
HCN channels are also modulated by adrenergic agonists via
cAMP (Bucchi et al., 2003; Craven and Zagotta, 2006).
If channels are also present in the human SAN. It has been
shown that HCN4 is strongly expressed in the human SAN,
with the measured mRNA level of other isoforms accounting for
<16% (with HCN3 being negligible, accounting for only 0.5%)
of the total mRNA measurement (Chandler et al., 2009). Though
the HCN expression in the human SAN is similar to that in the
rabbit, properties and kinetics of If are clearly different. It has
been shown the fully-activated If conductance in the human is
about 3–4 times smaller than that in the rabbit (Verkerk et al.,
2007a). Additionally, If in human SAN cells has a more negative
half-maximal activation voltage, and a greater time constant of
deactivation/activation process which is also negatively shifted
(Verkerk et al., 2007a). With such a marked species differences
in If conductance and kinetics between the rabbit and human, a
question arises as to whether a smaller If in the human SAN cells
plays the same important role in regulating cardiac pacemaking
activity as in the rabbit SAN?
Although If in human SAN cells is much smaller than
those in other mammals, it may play a comparable role
to that in the rabbit in modulating cardiac pacemaking. In
their study, (Verkerk et al., 2007b) observed about a 26%
increase in pacemaking cycle length in human SAN cells on
complete block of If by using 2mM Cs
+, which is close to
that seen in the rabbit (Verkerk and Wilders, 2010; Fabbri
et al., 2017). Pharmacological targeting of If by ivabradine has
also shown the clinical value of If in controlling the heart
rate in patients who need heart rate control in conditions
of coronary artery disease (CAD) (Tardif et al., 2005; Camici
et al., 2016; Niccoli et al., 2017) and heart failure (HF)
(Bohm et al., 2015; Yancy et al., 2016). In both conditions,
slowing down the heart rate by ivabradine increases the
diastolic interval, thereby reducing the metabolic load on the
working myocardium; this reduces the risks of ischemia of the
heart leading to reduced risk of sudden death (Niccoli et al.,
2017).
Although inhibition of If by ivabradine provides an efficient
pharmacological control of heart rate in the clinic, it is still
unclear how the clinical concentration range of ivabradine [about
20–140 nM (Choi et al., 2013; Jiang et al., 2013); blocking If
< 20% (Bois et al., 1996; Bucchi et al., 2002)] can produce a
significant effect in reducing human heart rate. In pre-clinical
animal model studies, ivabradine has been reported to inhibit If
in SAN cells with a half-maximal inhibitory concentration of 1.5–
2.8µM (Bois et al., 1996; Bucchi et al., 2002), and recombinant
HCN4 channels with an IC50 values between 0.5 and 2.0µM
(Bucchi et al., 2002, 2006, 2013). In rabbit SAN cells, 1µM
ivabradine has been observed to reduce the pacemaking rate by
12.3% (Thollon et al., 1994), whilst about 16.2 and 23.8% of heart
rate reduction at 3µM have been seen (Thollon et al., 1994;
Bucchi et al., 2007).
When ivabradine was administered intravenously (0.2mg
kg−1) to patients with normal baseline electrophysiology, mean
heart rate reductions of 12.9 and 14.1 beats min−1 (at 0.5
and 1 h respectively following administration) were observed
(Camm and Lau, 2003). The drug is usually administered
orally, however, and after repeated oral dosing at 5mg, mean
maximal plasma (Cmax) levels of 11–16 ng ml
−1 (23.5–
34.1 nM) have been measured, whilst for repeated dosing at
10mg, mean Cmax levels of 29–42 ng ml
−1 (61.8–89.6 nM)
have been seen (Choi et al., 2013; Jiang et al., 2013).
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Repeated dosing with a high ivabradine concentration of
20mg has been associated with a Cmax of 137 nM (Jiang
et al., 2013). On the basis of the pre-clinically observed
concentration-dependence for If inhibition, comparatively low
levels of If block might be expected at such plasma levels
(Thollon et al., 1994; Bucchi et al., 2007). However, clinical
concentrations of ivabradine produce about 18–20% reduction
in human heart rate (Camm and Lau, 2003; Doesch et al.,
2007).
Previous animal model studies (Difrancesco, 1991, 2010)
have found that inhibition of If by ivabradine slowed down
the spontaneous firing rate of the rabbit SAN cell in a use-
dependent manner (Bois et al., 1996), and about 15% reduction
of the pacemaking rate was observed at a concentration of 3µM,
which produced about 60% If reduction at membrane potential
of −92mV, and about 41% If reduction at physiologically
relevant membrane potentials (∼60mV) (Yaniv et al., 2012).
Numerically, in a recent in silico exploration of the role
of If in SAN pacemaking using a rabbit SAN model, the
effect of ivabradine was simulated through implementing a
66% reduction of If (mimicking an experimentally reported
effect of 3µM ivabradine), leading to a 22% reduction in
spontaneous rate (Severi et al., 2012). However, due to the
non-linear concentration-dependent action of ivabradine on If,
it is hard (if not impossible) to derive the effect of a low
concentration of ivabradine from that of a high concentration
on modulating cardiac pacemaking rate. To date, therefore, the
effect of blocking If at the level of If reduction at clinical plasma
levels of ivabradine (<20%) on pacemaking rate of the rabbit
SAN has not been elucidated, as is how such concentration can
produce a marked effect on the human SAN, in which If is
much smaller than that in the rabbit SAN. Most importantly,
it is unclear either how clinical concentrations of ivabradine
affect cardiac pacemaking activity in vivo as compared to those
predicted by single cell experiments in vitro, in which vagal tone
modulation of cardiac pacemaking is missing. The aim of the
present study was therefore to investigate through simulations
and theoretical analysis the effect of If reduction over a wide
range of values on cardiac pacemaking activity in the presence
and absence of vagal tone modulation of cardiac pacemaking
activity by acetylcholine.
METHODS
SAN Cell Model and If Formulations
In this study, the contemporary model of rabbit SAN cells
developed by Severi et al. (2012) was used as a basal model. The
model was chosen as it represents the most updated progress
in the model development of rabbit SAN cells, in particular
it incorporates an updated If formulation based on recently
available experimental data (Altomare et al., 2003; Barbuti et al.,
2007). The basal model code was downloadable from cellML
at the following URL: https://models.physiomeproject.org/e/139;
and the source codes used for this study are available on request
to: henggui.zhang@manchester.ac.uk. In brief, the dynamics of







itotal = ICaL + ICaT + IKr + IKs + Isus +
Ito + INaK + INaCa + INa + If
Where V is the membrane potential, Cm the membrane
capacitance, t the time, Itotal the total membrane current
generated by potassium (IKr, IKs, Isus, Ito), calcium (ICaL, ICaT),
sodium (INa), Na
+-K+ pump (INaK), Na
+-Ca2+ exchanger
(INaCa), and funny (If) channels. More details of the basal model
are documented in the study of Severi et al. (2012).
Previous experimental studies have shown some distinctive
differences in the maximal macroscopic conductance, the steady-
state activation curve and the time constant of the channel
activation of If between the rabbit and the human SAN cells
(Difrancesco et al., 1989; Altomare et al., 2003; Barbuti et al.,
2007; Verkerk et al., 2007b). In order to take into consideration
the reported species difference in If properties, in our simulations
we implemented two different sets of If formulations, one is
the original model formulations developed by Severi et al.
(2012) (rabbit-like formulation), and the other is Fabbri et al.
formulation (Fabbri et al., 2017) based on the human If data
(Verkerk et al., 2007b) (human-like formulation), which takes
the form:
If = If,Na + If,K
If,Na = gf,Na · y · (V − ENa)
If,K = gf,K · y · (V − EK)
τy =
1
(0.36 · (V + 148.8)/(e0.066·(V+148.8) − 1)+ 0.1 · (V + 87.3)/(1− e−0.21·(V+87.3))
− 0.054
y∞ = 0.01329+ 0.99921/(1+ e
(V+97.134)/8.1752),
if V < −80mV
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where If,Na and If,K are Na
+ and K+ components of If, gf,Na
(0.00268 µS) and gf,K (0.00159 µS) conductance of If,Na and If,K.
ENa and EK the equilibrium potential for Na
+ and K+. y∞ is the
steady state activation variable, τ y the time constant of activation
variable (y).
To determine and validate the parameters in the equations
of human-like and rabbit-like If formulations, the equations for
the steady-state activation curves (Figure 1A), and the equation
for the activation time constant (Figure 1B) were fitted to
experimental data obtained from human and rabbit SAN cells
respectively (Difrancesco et al., 1989; Altomare et al., 2003;
Barbuti et al., 2007; Verkerk et al., 2007b). The developed
If formulations were validated by their ability to reproduce
experimental I-V relationship data (Figure 1C) obtained by
running a series of voltage-clamp commands (Figure 1D) for
both the human-like and rabbit-like formulations. Figure 1
shows clearly that If in the human SAN has a more negative half-
maximal activation voltage (Figure 1A), a greater activation time
constant (i.e., slower activation process (Figure 1B) and a smaller
current density (Figure 1C) than that in the rabbit SAN.
Simulating the Effects of If Blockade
It has been shown that ivabradine blocks If without affecting
channel kinetics, with block leading to a constant level of If
reduction after a period of transition (Bucchi et al., 2002, 2013).
Therefore, in this study, we implemented a pore-block theory
(Yuan et al., 2015) to simulate the steady-state effect of If blocking
by ivabradine over a wide concentration range by reducing its
conductance by a factor k (k∈ (0,1), mimicking 0–100% (Bucchi
et al., 2013) of If reduction. With varying levels of If inhibition,




fNa = (1− k) · gfNa
g
′
fK = (1− k) · gfK
Simulating the Effect of Acetylcholine
(ACh)
In vivo, ACh released from vagal activity slows down the
spontaneous pacing rate of the SAN mainly by inhibiting If and
ICaL (Boyett et al., 1995), and activating acetylcholine-dependent
K+ current (IKACh) (Voigt et al., 2014). Vagal activity may also
play a significant role in slowing down the pacing rate when
ivabradine blocks If. To test the combined action of ivabradine
and ACh, we simulated the ACh effect on SAN spontaneous
APs, based on the formulations of Severi et al. (2012) for If
and ICaL inhibition, as well as IKACh activation. In simulations,
the values of gK,ACh used were the same as those used in the
Severi et al. (2012) and Fabbri et al. models (Fabbri et al.,
2017) for the human-like model (Severi model with human-
like If) ((Fabbri et al., 2017) and the rabbit-like model (i.e.,
the Fabbri et al. model with rabbit-like If; see details in the
Supplementary Material) (Severi et al., 2012). Effects of ACh on
pacemaking APs were qualitatively analyzed and compared with
the implementation of rabbit-like and human-like If formulation,
as well as If blocking. Details of the IKACh formulation were listed
in the Supplementary Material.
Study of Model-Dependence
In order to test the model-dependence of results, simulations
were also conducted in the Fabbri et al. model of the human
SAN cell (Fabbri et al., 2017), the source code of which was
downloadable from cellML at the following URL: https://models.
physiomeproject.org/e/568?searchterm=human++si. In this case,
the Fabbri et al. model with the human-like If formulation was
taken as the basal model, which was then modified by replacing
the If formulation by the rabbit-like one.
Although simulated action potentials from the original Fabbri
et al. (2017) model closely match experiment data of AP
properties and calcium transient of human SAN cells, some
modification was necessary as most of the ionic currents in
the model (except If, IKr, and IKs) were based on rabbit SAN
cell model, densities of which were modified by automatic
optimization to match simulated action potential characteristics
to experimental data. Such automatic optimization of model
parameters may deviate from physiological relevance, resulting
in some limitations. For example, a full block of ICaT in the
model abolished the pacemaking action potential. Though there
are no direct experimental data from human SAN cells to validate
the simulation result, data from rabbit sinoatrial node (Hagiwara
et al., 1988; Takeda et al., 2004) and human patients (Madle et al.,
2001) suggested a more modest change in the pacemaking cycle
length when ICaT was blocked. Therefore, we updated the model
to address some of the limitations. Details about model updating
and validations are presented in Supplementary Figure 1. Using
the updated model, simulations in the Serveri et al. model were
repeated in the Fabbri et al. model, and results are included in
the Supplementary Material to support the major conclusion of
the study.
Numerical Scheme
A fourth-order Runge-Kutta-Merson numerical integration
method was used to solve the ordinary differential equations of
the model. The time step was 5 × 10−6 s, which gives a stable
solution of the equations and maintains the accuracy of the
computation of membrane current and potential. In simulations,
action potentials after the 20th one were recorded for analysis.
For solving the Severi et al. model with the human If formulation,
a set of initial values were used, which were taken from the
recorded state variables when the model reached its steady state
(see details about the initial values for solving the model in the
Supplementary Material). This allows the secondary effect of
different If formulations to other channel variables of the models
to be considered in the simulations.
Theoretical Analysis
Theoretical analysis of the effect of If block on altered cardiac
pacemaking cycle length (CL) was conducted following a similar
approach as implemented in previous studies (Rocchetti et al.,
2000; Zaza and Lombardi, 2001; Monfredi et al., 2014; Winter
and Shattock, 2016; Zaza, 2016).
Figure 2 shows a schematic illustration of a cycle of action
potentials of SAN cells. During the time course of the action
potential, the voltage difference between the MDP and the
voltage at the beginning of AP upstroke (Vup) (1Vm) can
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FIGURE 1 | Kinetics of If from experimental and mathematical modeling data. (A) Steady-state activation curves in rabbit and human and SAN cells, which were used
to fit If formulations for the Severi et al. (2012) rabbit (solid lines) and the modified Fabbri et al. (2017) human (dashed lines) models. Experimental data from Altomare
et al. (2003) (N), Barbuti et al. (2007) (H), and Verkerk et al. (2007b) () are also shown. (B) Corresponding activation time constant of If for human and rabbit SAN
cells. Experimental data from Difrancesco et al. (1989) () and Verkerk et al. (2007b) () are also shown. (C) Computed I-V relationship for the human- (dashed line)
and rabbit-like (solid line) models, which are compared with experimental data from the study of Verkerk et al. (2007b) () for the human SAN cells, Zaza et al. (1996)
() and Goethals et al. (1993) (N) for the rabbit SAN cells. (D,E) Voltage-clamp protocol and simulated time traces of If during voltage-clamp for the rabbit and human
If model. (F) Dose-dependent effect of ivabradine on If in rabbit SAN cells. Experimental data of Bois et al. (1996) (•) and Bucchi et al. (2002) (N) were based to
develop the concentration-response curves as shown by the solid line and dashed line respectively.
be discretized as many small steps by 1Vi, each taking a
time period DIi to complete. Here dVi/dt represents the
local diastolic depolarization rate (DDR). During the diastolic
depolarization phase, with small time interval (dt), |dVi/dt| can
be approximately considered as a constant and denoted by























Considering Equation (2), the pacemaking cycle length (CL) can
be denoted as:









Where Itotal denotes total membrane currents during the diastolic
depolarization phase.
In response to If block, a new total ion channel current during




total = Itotal − 1I
1I is the change of Itotal caused by If reduction. This produces a














where APD’ is the new action potential duration in response to
If blockade. As a small If block in response to a low dose of
ivabradine mainly affects the diastolic depolarization phase and
has little or no impact on the AP duration and the MDP, APD′
is approximately equal to APD. Therefore, the increased cycle
length (1CL) can be represented as
1CL = CL
′









|Itotal| · |Itotal − 1I|
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FIGURE 2 | Schematic illustration of a cycle of SAN cell action potentials.
During one cycle, the time interval between two consecutive action potentials
measures the intrinsic pacemaking CL, which can be considered as a sum of
the AP duration (APD) and the diastolic interval (DI) which starts from the
maximum diastolic potential (MDP) to the beginning of AP upstroke [Vup
(Fabbri et al., 2017)]. 1Vm denotes the voltage difference between the MPD
and the Vup. During the DI, multiple time intervals (dt) were needed for the
membrane potential to transit from the MDP to the Vup, during each of which a
1Vi is generated.
By denoting p as If current block potency (p = |1I/If|), and x
as the proportion of If to Itotal during the diastolic phase (x =



































where C1 (C1 > 0) can be considered as a constant during the
diastolic depolarization phase with a fixed level of If reduction
(i.e., p is fixed), which has no significant effect on the difference


























Where C2 also can be seen as a constant related to C1 and p, also
with a fixed level of If reduction.
With If block, the resultant relative change of the CL predicted
by Equation (3) is inversely proportional to the amplitude of Itotal
during the diastolic depolarization phase, which determines the
intrinsic CL of the pacemaking action potential. It is also related
to the level of If reduction and the ratio between If and Itotal. With
a small level of If block, the resultant relative change of CL is
greater for a smaller Itotal (i.e., greater when the CL is larger or
the heart rate is lower).
RESULTS
Simulation Results
Figure 3 shows the simulated action potentials from the
Severi et al. model with rabbit (Figures 3Ai–Fi) and
human (Figures 3Aii–Fii) If formulations. In the figure,
action potentials (Figures 3Ai,Aii) are shown together with
membrane currents during the genesis of action potentials,
including ICaL (Figures 3Bi,Bii), If (Figures 3Ci,Cii),
INa (Figures 3Di,Dii), ICaT (Figures 3Ei,Eii), INaCa
(Figures 3Fi,Fii), IKr (Figures 3Gi,Gii), IKs (Figures 3Hi,Hii),
Ito (Figures 3Ii,Iii), and INaK (Figures 3Ji,Jii). By replacing
the rabbit If formulation with the human If formulation, the
pacemaking activity was slowed down, with a pacemaking CL
that increased from 355ms to 1,139ms, which was associated
with a slight increase in INa and ICaT at the late period of
the diastolic depolarization phase (DDP) (with no noticeable
difference at the initial period of the DDP), and a slight
decrease in IKr, IKs, Ito, and INaK during the DDP. Such a
small increase in the above-mentioned inward currents and a
decrease in the outward currents, though contributory factors,
are not the major determinants of the prolonged diastolic
depolarization phase. The slowing down in the pacemaking
activity of the human-like formulation model is mainly
attributable to the smaller If, ICaL, and INaCa during the diastolic
depolarization phase.
In Figure 3, effects of reducing If by 20% on the pacemaking
activity of the two models are also shown.
Reduction of If by 20% produced an increase of the CL in the
rabbit-like If formulation model by about 4.6% (Figure 3K). This
is in agreement with experimental data from isolated rabbit SAN
cells, which showed that a low level of If block by ivabradine
[<0.5µM, a concentration not affecting SAN ICaL which only
slightly decreased by 18.12 ± 0.66% at 10µM (Bois et al., 1996)]
produced only a slight slowing down of the pacemaking rate,
while >50% If blockade by 3µM ivabradine (see Figure 1F) only
reduced the spontaneous pacing rate by 11–17.7% (Bucchi et al.,
2007; Yaniv et al., 2012).
However, in the human-like If formulation model, If
reduction by 20% produced a more than 2-fold increase in
the pacemaking CL by 12.4% (i.e., equivalent to about 11.1%
reduction in the heart rate) as compared to the rabbit-like model
(Figure 3K). The pacing rate reduction though was slightly less
than the effect of intravenous administration of ivabradine by 0.2
mg·kg−1 (∼23.5–34.1 nM of mean maximal ivabradine plasma
levels) produced a reduction of heart rate by 18–20% (i.e., mean
heart rate reductions of 12.9 and 14.1 beats min−1; Camm and
Lau, 2003; Jiang et al., 2013), but close to experimental data of the
pacing rate reduction when If was blocked by 3µM ivabradine in
rabbit SAN (Bucchi et al., 2007; Yaniv et al., 2012). This illustrates
that the small human-like If has a greater effect on slowing down
the pacing rate than the rabbit-like one when If is inhibited
by ivabradine.
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FIGURE 3 | Simulated spontaneous action potentials and underlying currents by the Severi et al. model with rabbit If (Ai–Fi) and human If (Aii–Fii) formulations.
Effects of blocking If by 20% on action potentials and underlying ionic currents (dotted lines) are also shown and superimposed with those in control condition (solid
lines). (Ai,Aii): action potentials; (Bi,Bii): ICaL; (Ci,Cii): If; (Di,Dii): INa; (Ei,Eii): ICaT; (Fi,Fii): INaCa; (Gi,Gii): IKr; (Hi,Hii): IKs; (Ii,Iii): Ito; (K) increase of pacing CL.
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The results above suggested that the increased CL induced
by 20% If reduction is proportional to the intrinsic cycle length
of the model, i.e., the greater the intrinsic CL (e.g., the model
with human-like If formulation) the greater the increase of
the CL. This observation was model-independent as shown in
Supplementary Figure 3, in which Fabbri et al. model of the
human SAN was implemented by using rabbit-like and human-
like If formulations. In the basal condition (Fabbri et al. model
with human-like If formulation), the CL was 810ms, which was
increased by 44ms with 20% If reduction (i.e., 5.5%). When the
rabbit-like If formulation was used, the pacemaking rate was
increased due to a larger If, resulting a CL of 355ms. With 20% If
reduction, the CL was increased by 18ms (i.e., 4.7%), which was
smaller than that when the human-like If formulation was used.
As shown in Figures 3Ci,Cii, a 20% reduction in the channel
conductance did not necessarily produce 20% reduction in If
amplitude during the time course of action potential, due to the
dependence of If on membrane voltage. To further investigate
this, we computed the average If during the diastolic phase
before and after 20% reduction in its channel conductance.
Results are shown in Supplementary Figure 2. It was found that
20% reduction in the channel conductance produced a similar
decrease in the avarage If in the rabbit-like (by 0.34 pA) and
the human-like model (by 0.22 pA), but the relative change
was greater in the latter model because of its smaller If in the
control condition. Such difference in the relative change of If may
also be one of the important reasons for the more pronounced
prolongation of the diastolic phase in model with human If
formulation. Note that in both models (rabbit-like and human-
like models), the relative change of If was smaller than 20%
though the channel conductance was reduced by 20%, due to the
voltage-dependence of the channel’s activation.
Further simulations were carried out to analyze possible
effects of the cross talk between the membrane clock (If) and
Ca2+ clock on modulating pacemaking action potentials in
response to If reduction. Figure 4 shows results for the rabbit-
like (Figures 4Ai–Ei) and human-like (Figures 4Aii–Eii) If
formulation models. Blocking If by 20% decreased intracellular
(cytoplasmic) Ca2+ transients ([Ca2+]i, Figures 4Bi,Bii),
the intracellular subspace Ca2+ concentration ([Ca2+]sub,
Figures 4Ci,Cii) and the Ca2+ content in the network SR
([Ca2+]nsr, Figures 4Ei,Eii). The diastolic level of [Ca
2+]sub
was reduced by 2.9 and 5% in the rabbit-like and human-
like If formulation model respectively, the decreased [Ca]sub
during the diastolic depolarization phase of the action potential
(Figures 4Ci,Cii) leads to a decreased INaCa (Figures 3Fi,Fii)
and ICaL (Figures 3Bi,Bii), especially during the later phase
of diastolic depolarization, which prolonged the later phase of
the diastolic depolarization in the human-like If formulation
model (Figure 4Aii). There was a negligible change in INa
(Figures 3Di,Dii) and ICaT (Figures 3Ei,Eii) during the diastolic
phase. Taken together with the observation of changes in INaCa
(Figure 3F), our simulation results imply that the slowing down
of the spontaneous action potentials in response to a low level
of If block (< 20%) may be mainly attributable to If reduction
(i.e., membrane clock), with some contribution from a crosstalk
between themembrane clock and Ca2+ clock in the later diastolic
depolarization phase.
Effects were also investigated of how a systematic change
in If density affects spontaneous pacemaker activity. Results
are shown in Figure 5, in which the computed CL (Figure 5A)
and its increase (Figure 5B) with If being blocked from
0 to 100% with 1% increment for the rabbit-like (closed
circles) and human-like If formulations (open circles). It
was shown that over the range 0–80%, If block produced
a greater CL increase with the human-like formulation than
in the rabbit-like model. With a low level of If reduction,
a linear relationship between the CL increase and If block
was seen (Figure 5B). However, the relationship changed to
an exponential one (Figure 5B) when a high level of If
block was implemented. With about 66% If reduction, the
CL was increased by about 26% (reduced pacemaking rate
by 21%) in the rabbit-like model, which is consistent with
experimental data (Thollon et al., 1994; Bucchi et al., 2007),
but by about 42% in the human If formulation. A low level
of If reduction (<20%) resulted in a negligible change in
the MDP (<-0.3mV in both models) in both rabbit-like and
human-like If formulation models, and 100% If reduction
hyperpolarised MDP by only 3.2mV in the latter model
(Figure 5C). Corresponding changes in APD90 (Figure 5D) and
the voltage at the beginning of AP upstroke (Figure 5E) were also
shown (also see Supplementary Table 1). While a high level of
If reduction hyperpolarized the MDP, it had modest secondary
effect on APD90 (mainly prolonging the late repolarization phase
which may be due to the decreased IKr and INaK as shown
in Supplementary Figures 4Gi,Ji, and there was no significant
change in the fundamental morphology of the action potential as
shown in Supplementary Figure 4Ai) and AP upstroke potential
in the rabbit-like model.
Changes of the membrane currents and ion concentrations
with a systematic change in If density in the two models
were also investigated (Supplementary Figures 3, 4).
During the diastolic depolarization phase of the action
potentials, [Ca]sub decreased as If density gradually decreased
(Supplementary Figures 3Ci,Cii), further leading to a slower
activation of the ICaL (Supplementary Figures 4Bi,Bii)
and a decrease in INaCa (Supplementary Figures 4Fi,Fii)
during this phase. Reduction of INaCa decreased [Na]i
(Supplementary Figures 3Fi,Fii), leading to a reduction
in INaK (Supplementary Figures 4Ji,Jii) which further
exacerbated the reduction of [Na]i. The outward currents
(IKr, IKs, Ito, INaK) also showed a gradual decrease with a
decreased If density during the diastolic depolarization phase
(Supplementary Figures 4Gi–Ji,Gii–Jii).
The simulated action potentials from the two models
showed some differences when If was fully blocked (Figure 5A),
with the rabbit-like model failing to generate spontaneous
action potentials. Such differences may be attributable to
the use of different sets of initial values recorded from their
steady state variables as there was no other changes in model
equations or parameters, except for the use of rabbit-like If or
human-like If formulations. In order to determine potential
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FIGURE 4 | Effect of If block on the Ca
2+ transient in rabbit-like (Ai–Ei) and human-like (Aii–Eii) SAN cell models. (Ai,Aii): the action potentials; (Bi,Bii): Ca2+
transient in the myoplasmic space; (Ci,Cii): Ca2+ transient in the myoplasmic sub-space; (Di,Dii): Ca2+ transients in the junctional SR; (Ei,Eii): Ca2+ transient in the
network SR space; (Fi,Fii): intracellular Na+ concentration. Simulation results in control (solid line) are superimposed on those of If blocking (dotted lines).
factors contributing to such differences or contributing to
the pacemaking action potentials in the two models, further
analyses on membrane currents and the intracellular Ca2+
transients between control and 99% reduction of If were
conducted. Results are shown in Supplementary Figures 3, 4.
It was shown that in both models, in addition to If, ICaT,
INaCa, and INa contributed to the diastolic depolarization.
With a high level of If reduction (99%), there was a significant
decrease in [Ca]sub during the diastolic depolarization phase
(Supplementary Figure 3Ci), causing a significant reduction
in INaCa (Supplementary Figure 4Fi). Consequently, the
spontaneous membrane depolarization was not able to reach the
ICaL activation potential, terminating the action potentials in the
rabbit-like model.
In the human-like model, a reduction of [Ca]sub was also
observed with a high level of If reduction, resulting in a decreased
INaCa. However INaCa was sufficient to maintain the spontaneous
depolarization to generate a full action potential.
The focus of this study was on the action of a modest extent
(i.e., <20%) of If bock, mimicking the clinical use of ivabradine,
rather than on the action of a large percentage of If block. With
<50% If block, the increase in CL was about <30%, which is
reasonably close to the experimental data observed in rabbit SAN
cells when If is blocked by use of Cs
+ (Nikmaram et al., 1997),
validating the physiological relevance of the results obtained.
Further simulations were conducted to investigate the
combined action of If reduction by ivabradine and actions of
ACh (Boyett et al., 1995), mimicking the autonomic regulation
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FIGURE 5 | Simulated effect of If block on the CL increase. (A,B) Pacing cycle length and the relative percentage changes of CL when If blocked from 0 to 100% with
1% increment in the human-like (open circle) and rabbit-like (closed circle) SAN cell models; (C,D) the maximum diastolic potential (MDP) and action potential duration
at 90% of repolarization (APD90); (E) change of the beginning of action potential upstroke voltage, which was calculated as the diastolic depolarization rate reached
about 50% of its maximum value. If block produced greater effect in the human-like (gray circle) and rabbit-like (black square) SAN cell models.
of cardiac pacemaking in vivo. In simulations, acetylcholine-
dependent inhibition of If and ICaL, and activation of K
+
current (IK,ACh) (Voigt et al., 2014) were considered. Results are
shown in Figure 6, in which computed time courses of APs in
control (with both rabbit-like and human-like If formulations), If
reduction alone (by 20%) and If reduction together with actions
of 0.1 nM ACh were compared (Figures 6A,B). It was shown
that ACh augmented the effect of If reduction on the increase
of CL in the model with both the rabbit-like and human-like If
formulations. With the action of 0.1 nM ACh, 20% of If block
increased the CL by 37.5% (about 27.3% reduction the pacing
rate) (Figure 6C) in the model with human-like If formulation,
which is remarkably greater than that of 10.1% (about 9.1%
reduction in the pacing rat) in the model with the rabbit-
like If formulation. This observation held true when different
ACh concentrations were considered (Figure 6D). These results
illustrate that the combined action of IKACh and If reduction
further slowed down the pacemaking AP due to a reduced total
depolarization current during diastolic depolarization phase,
resulting in a greater CL prolongation. It suggested that the
clinical observed effect of low ivabradine on reducing pacing rate
may partially result from the action of ACh due to active vagal
tone in vivo. Similar observations were also seen in the Fabbri
et al. model as shown in Supplementary Figure 4, in which ACh
augmented more the effect of If reduction on pacemaking rate in
the model with human-like If formulation than that with rabbit-
like If formulation. Results from the Fabbri et al. model were
similar, as shown in Supplementary Figure 5.
Theoretical Analysis Validation
The simulation results presented above showed that If block
produced a greater impact on slowing down the pacemaking
rate with the human-like If formulation than that in the
rabbit-like cell model in both the Severi et al. and Fabbri et al.
model (see Supplementary Material). This is paradoxical as
the If density over the pacemaker range with the human-
like formulation is much smaller than that in the rabbit-like
model, and one would expect a smaller If contribution to
the spontaneous action potentials (therefore a smaller CL
increase with If block). However, such a paradoxical effect
of If reduction on the increase of CL as observed in the
two models matched the theoretical prediction shown in
the Method section (Equation 2), which showed an inverse
relationship between an increased CL and the amplitude
of total ionic membrane currents during the diastolic
depolarization phase. With the theoretical prediction, a
greater CL increase in the human-like If formulation SAN cell
model can be attributed to a smaller Itotal during the diastolic
depolarization phase.
To test the theoretical prediction, further analyses were
conducted to compute the averaged Itotal amplitude during
the DDP. Results from the Severi et al. model are shown in
Figure 7 for control and 20% If reduction for action potentials
(Figures 7Ai,Aii), the time course of Itotal (Figures 7Bi,Bii)
and the averaged amplitude of Itotal (Figure 7C) during
the DDP. It was found that during the time course of
diastolic depolarization, the averaged Itotal amplitude in
the cell model with the human If formulations was much
smaller (<30%) than that in the rabbit-like model, which
produced a slower pacemaking rate (i.e., longer CL) and
greater CL increase in response to 20% If reduction, matching
the theoretical prediction. The changes in currents and
Ca2+ ion concentration associated with the change in
Itotal (Figures 7Bi,Bii) are shown in Figures 3, 4. A similar
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FIGURE 6 | Effects of combined action of ACh and 20% If reduction on sponteneous action potentials in the Severi et al. model with the rabbit-like and human-like If
formulations. (A,B) Time courses of action potentials in control, If reduction and combined effect of If reduction and ACh (0.1 nM). (C) The increase of pacemaking CL
in the conditions of 20% If block alone and combined action with ACh (0.1 nM). (D) Combined effect of variant concentrations of ACh (from 0.1 to 10 nM) and 20% If
block on pacemaking CL in the rabbit-like and human-like If formulations models.
observation was also seen in the Fabbri et al. model as shown in
Supplementary Figure 6C.
In theoretical analysis it was shown that the relative increase of
CL was also influenced by a factor of 1
|1/x−p|
, which was related to
the ratio of If to Itotal (x) and If block potency (p). In simulations,







control and If reduction cases. Results from the Severi et al. model
are shown in Figure 8, in which the time courses of 1
|1/x−0.2|
(Figures 8Ai,Aii) and 1
|Itotal|
· 1
|1/x−0.2| (Figures 8Bi,Bii) were
plotted for the control (black) and 20% If reduction (p = 0.2)
for the rabbit-like (left panels) and human-like (the right panels)
models. The computed 1
|1/x−0.2| (acting as a piecewise function)
was set to 1
1×10-3
when |1/x− 0.2| was smaller than 1 × 10-3 to
avoid the value close to positive infinity. It was shown that in
both models with a small If block the difference in the computed
value of 1
|1/x−p|
between control (solid line) and 20% If reduction
(dotted line) was very small during diastolic depolarization phase,




|1/x−0.2| ). This provides support for the notion that the
relative increase of CL was mainly determined by the amplitude
of Itotal during the diastolic depolarisation phase in response to
If block.
Note that during the last period of diastolic depolarisation
phase (i.e., during time period of 310–387ms as shown in
the figure for the rabbit-like model and 890–1,331ms for the






|1/x−0.2| became more noticeable. This may
be attributable to the different timings by which the upstroke
of pacemaking actions potentials occurred between control and
If reduction conditions. Note that the value of
1
|1/x−0.2|was also
greater in the human-like model than that in the rabbit, which
amplified the contribution of 1
|Itotal|
toward a relative increase of
CL. Results from the Fabbri et al. model were similar, as shown in
Supplementary Figure 7.
A marked difference in the V1/2 of the steady-state activation
relationship (y∞) of If between the rabbit and the human SAN
cells has been observed (Difrancesco et al., 1989; Altomare et al.,
2003; Barbuti et al., 2007; Verkerk et al., 2007b). In this study,
we used V1/2 of −52.5 and −97.1mV for the rabbit-like and the
human-like If formulation respectively. In order to systematically
determine a possible role of varying V1/2 in modulating If
amplitude, and thus the Itotal and the effect of If reduction on
the increase of CL, we changed V1/2 of y∞ in the human-
like If formulation in a border range from −50 to−70mV.
Results from the Serveri et al. model are shown in Figure 9
for the pacemaking CL (Figure 9A), the averaged Itotal during
diastolic depolarization phase (Figure 8B), and increase of CL
(Figure 9C) with 20% If block. Shifting the V1/2 from−50mV
(about rabbit V1/2) to−70mV (about human V1/2), the Itotal was
decreased (Figure 9B), which were correlated with an increased
CL (Figure 9A) as well as an increased effect of If reduction on
CL (Figure 9C). These results supported our theoretical analysis
on that a smaller If in the model resulted in a smaller Itotal
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FIGURE 7 | Simulation of the inverse relationship of Itotal and the increasing of CL in control (solid lines) and 20% If reduction (dotted lines) to validate theoretical
analysis result (Equation 2) in method section (p = 0.2, modeling 20% If reduction). (Ai,Aii) Time course of action potentials for rabbit-like and human-like SAN cell
models respectively (gray lines represents diastolic depolarization voltage changes from the MDP to the voltage at the beginning of AP upstroke in control condition);
(Bi,Bii) time courses of Itotal (gray lines represents diastolic depolarization voltage changes from the MDP to the voltage at the beginning of AP upstroke in control
condition). (C) Averaged value of Itotal amplitude during the diastolic depolarization phase for the rabbit-like (black) and human-like (gray) SAN cell models. In each
case, the integral interval was set to the time interval between the MDP and beginning of the upstroke membrane potential (Vup).
amplitude, resulting in a slower pacemaking rate; and as such
the same reduction in If resulted in a more significant change
of CL in the cell model with a smaller Itotal. Similar results
were also observed using the Fabbri et al. model as shown in
Supplementary Figure 8.
DISCUSSION
This study was conducted to determine the mechanism by which
a low level of If block by clinical drug (ivabradine) concentration
is able to reduce the heart rate of patients by about 18–20%.
In a previous study, Verkerk and Wilders found that though If
has a small magnitude in the human SA node cells, it has an
equally important role as in the rabbit (Verkerk and Wilders,
2010). In another study, Maltsev and Lakatta argued that If
provides a relatively modest contribution to spontaneous beating
rate regulation of human and rabbit sinoatrial node cells, and
its major role in human SAN cells is to prevent excessive
hyperpolarization during AP repolarization, thus representing
an anti-bradycardic mechanism, rather than a primary rate
regulatory mechanism (Maltsev and Lakatta, 2010). Though
these previous studies addressed how a smaller If can produce
the same effect in humans with respect to rabbit (Verkerk and
Wilders, 2010; Fabbri et al., 2017) on complete If block, however,
the question on how <20% If block produces a marked heart
rate reduction in humans in vivo had remained unclear. This is
due to the nonlinear relationship between the extent of If block
and heart rate reduction (see Figure 5); effects of partial If block
cannot be predicted with certainty from the complete block data
already in the literature.
The principal contributions of the work are insights into how
a small extent of If block (<20%; as may occur during clinical use
of ivabradine) produces a marked heart rate reduction in human
SAN, greater than that predicted by single cell experiments in the
rabbit though the latter has a greater If density. Our principal
findings are: (i) blocking If by 20% resulted in only about a
4.6 % increase in the CL in the rabbit-like SAN cell model,
but about 12.4% in the cell model with human If formulation.
This finding suggests that If block has a greater effect with
the human-like SAN cell If formulation than with rabbit-like
If formulation, despite the fact that the former has a smaller
If current density over diastolic potentials, based on which one
might expect a smaller contribution of If to pacemaking; (ii) there
is a cross-talk between the membrane clock and Ca2+ clock with
20% If block in the later phase of the diastolic depolarization
of the action potential; (iii) a theoretical analysis matching
the simulation data has been produced, providing a numerical
formalism explaining the relationship between If block effects
and its contribution to total current during diastolic phase. In
this study, both numerical simulations and theoretical analysis
here have attributed the paradoxical effect of If reduction (i.e.,
a greater effect in SAN cells with smaller If current density
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|1/x−p| to validate theoretical analysis result (Equation 2) in method section (p = 0.2, modeling 20% If reduction).
The highlighted lines shown in this figure are during the diastolic depolarization phase of the action potentials of control (solid lines) and 20% If reduction (dotted lines)
cases for the rabbit-like (Ai,Bi) and human-like (Aii,Bii) SAN cell models.
FIGURE 9 | (A–C) Effect of varied half-activation voltage (V1/2 ) of the steady state activation variable (y∞) on pacemaking CL in the Serveri et al. model with
human-like If formulation. V1/2 changed from −50 to −70mV, covering the experimental data range for rabbit (−50mV) and human (−97.1mV) SAN cells.
and therefore a slower heart rate) to an inverse relationship
between the relative increase of CL and the amplitude of the total
current during the diastolic depolarization phase in response to If
block; and (iv) significantly, vagal tone activity viaACh augments
the effects of ivabradine on heart rate reduction, providing a
possible mechanism(s) by which the clinical concentrations can
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have larger effects in vivo than those predicted by single cell
experiments in vitro. It has been shown that combined action
of ACh (0.1 nM) and 20% If reduction markedly increase the
pacemaking CL by 37.5%, close to the clinical effect of ivabradine
when human-like If formulation was used, which is significantly
greater than that of 10.1%when the rabbit-like If formulation was
used. These findings were also observed in the Fabbri et al. model.
The results of the present study demonstrate and explain
why a smaller human If has a greater effect on prolonging the
diastolic depolarization phase when it is partially blocked, using
both mathematical theoretical analysis and computer simulation,
which is clearly distinct from the previous studies (Verkerk
and Wilders, 2010; Fabbri et al., 2017). Collectively, they add
mechanistic insight into the understanding of how a low dose of
clinical use of ivabradine (<137 nM) can effectively slow down
the human heart rate by about 18–20% (Camm and Lau, 2003;
Joannides et al., 2006; Doesch et al., 2007; Jiang et al., 2013),
which contrasts with a negligible effect predicted by experimental
studies in the rabbit (<4% at 10min after administration of
ivabradine; Thollon et al., 2007).
Role of If in Generating Cardiac
Pacemaking Activity
If channels encoded by HCN genes are richly expressed in
cardiac conduction systems including the primary pacemaker,
the SAN (Altomare et al., 2003; Ravagli et al., 2016). Previous
studies from animal models have suggested an important role of
If in the SAN (Difrancesco and Noble, 2012; Baruscotti et al.,
2016; Kozasa et al., 2018). It has been shown that a complete
block of If by Cs
+ (2mM) slowed down the pacemaking rate
by 30% in the rabbit SAN cells (Denyer and Brown, 1990), a
17.6% reduction of pacemaking rate also seen when blocking
of If with 0.5 mmol/L Cs
+ (Liu et al., 2008). In transgenic
mice, knocking down HCN4 produced bradycardiac effects
as well as atrioventricular node conduction block (Herrmann
et al., 2007; Hoesl et al., 2008; Baruscotti et al., 2011). All
of this evidence demonstrates that If, together with the more
recently identified Ca2+ clock [arising from the coupling between
the intracellular Ca2+ cycling and electrogenesis of membrane
currents (e.g., INaCa) (Maltsev and Lakatta, 2008; Lakatta and
Difrancesco, 2009)], provide a major driving force for generating
the spontaneous depolarization during the diastolic phase that
leads to intrinsic pacemaker activity.
If is also present in human SAN cells (Verkerk et al., 2009b; Li
et al., 2015) and contributes to pacemaking. It has been shown
that loss-of-function of HCN channel mutations is associated
with sick sinus syndrome, which manifests with symptoms
of bradycardia and conduction block (Schweizer et al., 2014;
Verkerk and Wilders, 2014, 2015). However, the functional role
of If in generating pacemaking action potentials of human SAN is
less well-characterized as compared to that from small mammals.
Limited data have shown that If in the human SAN cells has a
smaller current density, more negative depolarised membrane
potential of half maximal activation and slower activation rate
as compared to the rabbit (Verkerk et al., 2007a,b, 2009b).
All of these suggested a smaller If current during the diastolic
depolarization phase, which may result in a slower heart rate.
Indeed this is the case as shown in the present simulation
study. In the Severi et al. model (Severi et al., 2012) with the
rabbit-like If formulation, the measured pacemaking cycle length
was 354.8ms. However, when the rabbit-like If formulation was
replaced by the human one, the pacemaking rate was slowed
down and the pacemaking cycle length increased to 1,139.4ms,
greater than the intrinsic pacemaking cycle length of native
human SAN cells [about 828 ± 21ms (Verkerk et al., 2007b)].
Note that in the model, such a significant increase of the
pacemaking CL from the one of rabbit SAN cells to the one close
to human SAN cells was mainly attributable to a small If, as no
change or negligible secondary changes of other ion channels
were implemented. This suggests that If exerts a strong influence
on pacemaker rhythm. Note that there is a marked difference in
the pacemaking CL between the human-like model (1,139.4ms)
and native human SAN cells [about 828 ± 21ms (Verkerk et al.,
2007b)], which may be due to possible species differences in the
properties of other membrane currents (Fabbri et al., 2017) and
Ca2+ clock (Tsutsui et al., 2018). With the increase of If blocking,
the pacemaking CL increased non-linearly in the model with
either rabbit-like or human-like If formulations.
In simulations, the action of 100% If block abolished the
pacemaking in the model with rabbit-like If formulations. This
may over emphasize the role of If in the rabbit SAN pacemaking
and is non-physiological. However, the focus of this study is on
the action of small If block (i.e., <20%), mimicking the use of
effect of ivabradine in practice, rather than on the action of large
percentage of If block. With <50% If block, the increase in CL is
about <30%, which is reasonably close to the experimental data
observed in rabbit SAN cells when If is blocked by use of Cs
+
(Nikmaram et al., 1997).
Mechanism for the Action of Low Dose
Ivabradine on Human SAN
Our theoretical and numerical simulation results have shown that
a low level of If block, mimicking the clinical concentrations
of ivabradine, produced a more marked effect in reducing the
heart rate of the human-like If formulation SAN cell model
than the rabbit-like If formulation SAN cell model. When the
action of ACh (0.1 nM) was considered, there was a further
reduction of sponteneous pacing rate (reduced upto by 27.3%),
which is close to the effect of ivabradine at clinical concentration.
Results from the Fabbri et al. model were similar, showing
that these observations are model-independent. All these results
suggest that a combined action of If reduction by ivabradine at
clinical concentrations and ACh are attributable to the heart rate
reduction as seen clinically (Camm and Lau, 2003; Doesch et al.,
2007).
It is possible that ivabradine regulates the heart rate by a
cross-talk between the membrane clock and Ca2+ clock via the
electrogenic Na+-Ca2+ exchangers (Yaniv et al., 2013). While the
direct action of ivabradine on the intracellular Ca2+ handling is
unclear, our simulation results showed that a 20% If reduction
produced secondary modulations of other ionic currents (e.g.,
INaCa) and the intracellular Ca
2+ handling, suggesting there
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is a cross-talk between the membrane clock and Ca2+ clock
in the late phase of the diastolic depolarization of the action
potential (Figures 4Bii–Eii). All these illustrated that ivabradine
affected the heart rate at clinical concentrations mainly through
regulating membrane clock and Ca2+ clock, and combining with
the action of ACh.
Limitations of the Study
Possible limitations of the Severi et al. model of the rabbit SAN
cells have been well-discussed and documented (Severi et al.,
2012). For example, as highlighted by Verkerk and Wilders
(2014), the reversal potential of If in the Severi et al. model
(−4.39mV) was more positive than that experimentally reported
(about −30mV) (Difrancesco et al., 1986; Van Ginneken and
Giles, 1991; Verkerk et al., 2009a), which is a limitation of the
Severi et al. model, and therefore also of studies employing this
model. However, we did not modify the If equation of the Severi
et al. model for the following reasons: (1) the simulated I-V
relationship data shown in (Figure 1C) lie within the range of
experimental data, and If is very small when the voltage is more
positive than−40mV; (2) when the voltage is more positive than
−30mV, the activation of ICaL is dominant, which contributes
mainly to the upstroke phase (non-diastolic depolarization
phase) of the action potential. Therefore, even if the reversal
potential of If is changed from −30mV to −4.39mV, it has
negligible effect on the diastolic depolarization of spontaneous
action potentials. Moreover, in simulations in which the rabbit-
like If was replaced by the human-like formulations in the Severi
et al. model, the reversal potential of If used was −27.5mV,
close to the experimentally determined value of −22.1 ± 2.4mV
(Verkerk et al., 2007b).
Another potential limitation of the present study relates to
modification of the Severi et al. model to incorporate the human
If formulation developed by Fabbri et al. based on experimental
data from human SAN cells. Due to lack of experimental data
from human SAN cells, equations and parameters for other ion
channels and transporters in the Severi et al. model were not
updated. Note that experimental data on the Ca2+ clock of the
human SAN became available recently (Tsutsui et al., 2018),
which are not incorporated in the model yet. This may explain
why the computed CL of the human-like SAN cell is greater
than that of natural human SAN cells, and consequently the
smaller effect of If blocking on the reduction of the heart rate
the clinical data. In addition, the action of low dose ivabradine
was simulated by considering its action on blocking If only,
and did not incorporate its possible actions on IKr as seen
in some experimental studies on ventricular cells/tissue at low
dose (Melgari et al., 2015) or high doses (Lees-Miller et al.,
2015). However, the present study deliberately focused on the
difference in direct effects of ivabradine on If in the SAN
cells between species (If in the rabbit SAN and in the human-
like SAN). Whilst it is necessary to point out these potential
limitations, nevertheless, the simulation data strongly supported
the mechanism demonstrated by the theoretical analysis in
showing the inverse correlation between Itotal during the diastolic
depolarization phase and the relative increase of the CL.
Therefore, these limitations do not alter our major conclusion on
the role of If block in modulating cardiac pacemaking activities
in the human SAN by low concentrations of ivabradine.
CONCLUSION
An inverse correlation between the relative increase of CL and
the amplitude of the total ion channel current during the diastolic
depolarization phase has been observed. Both theoretical analysis
and simulations have shown that a low level of If block (<20%)
can produce a more marked reduction of in the pacemaking rate
of the human-like SAN cell model than the rabbit-like one due to
its smaller Itotal during the diastolic depolarization phase. This
was particularly the case when ACh actions were considered,
which amplified the pacemaking cycle length prolongation. This
study thus provides a mechanistic explanation into how a low
level of If block by the clinical concentrations of ivabradine can
effectively reduce the heart rate in humans but produce a small or
negligible effect in the rabbit.
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